Showing results (191-200 of 411) with videos related to
Sort By:
Pageof 42
Virology|November 12, 2013
Simian adenovirus type 35 has a recombinant genome comprising human and simian adenovirus sequences, which predicts its potential emergence as a human respiratory pathogenShoaleh Dehghan, Jason Seto, Morris S Jones, et al.Proceedings of the National Academy of Sciences of the United States of America|September 9, 2020
CSF1R inhibition by a small-molecule inhibitor is not microglia specific; affecting hematopoiesis and the function of macrophagesFengyang Lei, Naiwen Cui, Chengxin Zhou, et al.Research Square|September 18, 2023
CSF1R inhibition is not specific to innate immune cells but also affects T-helper cell differentiation independently of microglia depletionFengyang Lei, Naiwen Cui, Chengxin Zhou, et al.Ophthalmology|August 20, 2016
Long-term Visual Outcomes and Complications of Boston Keratoprosthesis Type II ImplantationRamon Lee, Ziad Khoueir, Edem Tsikata, et al.FEBS Letters|November 27, 2019
Genomic foundations of evolution and ocular pathogenesis in human adenovirus species DAshrafali Mohamed Ismail, Xiaohong Zhou, David W Dyer, et al.Journal of Clinical Microbiology|January 1, 2010
Computational analysis identifies human adenovirus type 55 as a re-emergent acute respiratory disease pathogenMichael P Walsh, Jason Seto, Morris S Jones, et al.Survey of Ophthalmology|December 28, 2018
The persistent dilemma of microbial keratitis: Global burden, diagnosis, and antimicrobial resistanceLawson Ung, Paulo J M Bispo, Swapna S Shanbhag, et al.Ophthalmic Plastic and Reconstructive Surgery|May 11, 2016
Eyelid Mass in Boston Keratoprosthesis Type 2Catherine J Choi, Anna M Stagner, Frederick A Jakobiec, et al.Journal of the American Academy of Dermatology|July 21, 2015
Melanocytic nevi excised during B-Raf proto-oncogene (BRAF) inhibitor therapy: A study of 19 lesions from 10 patientsMark C Mochel, Marc R Hammond, Dennie T Frederick, et al.Ocular Immunology and Inflammation|April 29, 2022
Relationship between Atopic Disease and Acute Ocular and Systemic Outcomes in Patients with Stevens-Johnson Syndrome/Toxic Epidermal NecrolysisJames Kwan, Harris Ahmed, Momoko K Ponsetto, et al.Pageof 42